US Albinism Drug Market: Advancements in Drug Development and Innovation
The US albinism drug market remains an emerging rare-disease segment, with research increasingly focused on therapies that could influence melanin production or address vision-related effects at a biological level. Investigational approaches such as nitisinone have demonstrated potential to increase melanin in certain forms of oculocutaneous albinism, while earlier clinical research with...
0 Комментарии 0 Поделились 125 Просмотры 0 предпросмотр
AC Mingle https://acmingle.com